Pituitary acromegaly: not one disease

T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly

(2016) Iulia Potorac et al.   ENDOCRINE-RELATED CANCER

Genetics of gigantism and acromegaly

(2016) Fady Hannah-Shmouni et al.   GROWTH HORMONE & IGF RESEARCH

Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas

(2016) Ozgur Mete et al.   MODERN PATHOLOGY

Recurrent gain-of-function USP8 mutations in Cushing's disease

(2015) Zeng-Yi Ma et al.   CELL RESEARCH

The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease

(2015) K. Hayashi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study

(2015) Donato Iacovazzo et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Differential somatostatin receptor (SSTR) 1–5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors

(2015) Katja Kiseljak-Vassiliades et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas

(2015) Judit Dénes et al.   PLoS One

Mutations in the deubiquitinase gene USP8 cause Cushing's disease

(2014) Martin Reincke et al.   NATURE GENETICS

Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naïve patients with somatotroph adenomas

(2013) Sarah Larkin et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas

(2013) Bernhard Mayr et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide

(2013) Olivera Casar-Borota et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Metabolic Glucose Status and Pituitary Pathology Portend Therapeutic Outcomes in Acromegaly

(2013) Sonia Cheng et al.   PLoS One

Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience

(2012) Jessica Brzana et al.   Pituitary

Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly

(2011) Stine Lyngvi Fougner et al.   CLINICAL ENDOCRINOLOGY

Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly

(2011) Ansgar Heck et al.   CLINICAL ENDOCRINOLOGY

Differential expression of genes related to drug responsiveness between sparsely and densely granulated somatotroph adenomas

(2011) Masako Kato et al.   ENDOCRINE JOURNAL

The FGFR4-G388R Polymorphism Promotes Mitochondrial STAT3 Serine Phosphorylation to Facilitate Pituitary Growth Hormone Cell Tumorigenesis

(2011) Toru Tateno et al.   PLoS Genetics

Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study

(2010) Adrian F. Daly et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Pathogenesis of Pituitary Tumors

(2009) Sylvia L. Asa et al.   Annual Review of Pathology-Mechanisms of Disease

Clinicopathological Features of Growth Hormone-producing Pituitary Adenomas: Difference among Various Types Defined by Cytokeratin Distribution Pattern Including a Transitional Form

(2008) Abdulkader Obari et al.   ENDOCRINE PATHOLOGY